These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25118887)

  • 1. Megakaryocytic potentiating factor and mature mesothelin stimulate the growth of a lung cancer cell line in the peritoneal cavity of mice.
    Zhang J; Bera TK; Liu W; Du X; Alewine C; Hassan R; Pastan I
    PLoS One; 2014; 9(8):e104388. PubMed ID: 25118887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells.
    He X; Wang L; Riedel H; Wang K; Yang Y; Dinu CZ; Rojanasakul Y
    Mol Cancer; 2017 Mar; 16(1):63. PubMed ID: 28288645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin.
    Iwahori K; Osaki T; Serada S; Fujimoto M; Suzuki H; Kishi Y; Yokoyama A; Hamada H; Fujii Y; Yamaguchi K; Hirashima T; Matsui K; Tachibana I; Nakamura Y; Kawase I; Naka T
    Lung Cancer; 2008 Oct; 62(1):45-54. PubMed ID: 18394747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mesothelin in carbon nanotube-induced carcinogenic transformation of human bronchial epithelial cells.
    He X; Despeaux E; Stueckle TA; Chi A; Castranova V; Dinu CZ; Wang L; Rojanasakul Y
    Am J Physiol Lung Cell Mol Physiol; 2016 Sep; 311(3):L538-49. PubMed ID: 27422997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exon deletion in the MSLN gene encoding MPF/mesothelin precursor protein during Laurasiatherian mammal evolution.
    Kim DS; Hahn Y
    Int J Mol Med; 2011 Feb; 27(2):289-93. PubMed ID: 21132261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation.
    Chen YL; Chang MC; Chiang YC; Lin HW; Sun NY; Chen CA; Sun WZ; Cheng WF
    Cancer Lett; 2018 Jul; 425():152-163. PubMed ID: 29596890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine.
    Chen V; Umemura S; Han Y; Raman R; Tucker R; Chahine J; Kim IK; Schatz C; Zitzmann-Kolbe S; Sommer A; Onda M; Lee T; He Y; Giaccone G
    Br J Cancer; 2022 Mar; 126(5):754-763. PubMed ID: 34876673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.
    Zhang S; Yong LK; Li D; Cubas R; Chen C; Yao Q
    PLoS One; 2013; 8(7):e68303. PubMed ID: 23874581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.
    Servais EL; Colovos C; Rodriguez L; Bograd AJ; Nitadori J; Sima C; Rusch VW; Sadelain M; Adusumilli PS
    Clin Cancer Res; 2012 May; 18(9):2478-89. PubMed ID: 22371455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.
    Kachala SS; Bograd AJ; Villena-Vargas J; Suzuki K; Servais EL; Kadota K; Chou J; Sima CS; Vertes E; Rusch VW; Travis WD; Sadelain M; Adusumilli PS
    Clin Cancer Res; 2014 Feb; 20(4):1020-8. PubMed ID: 24334761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment.
    Hilliard TS; Kowalski B; Iwamoto K; Agadi EA; Liu Y; Yang J; Asem M; Klymenko Y; Johnson J; Shi Z; Marfowaa G; Yemc MG; Petrasko P; Stack MS
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serum.
    Creaney J; Sneddon S; Dick IM; Dare H; Boudville N; Musk AW; Skates SJ; Robinson BW
    Dis Markers; 2013; 35(2):119-27. PubMed ID: 24167356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cells.
    Kobayashi K; Sasaki T; Takenaka F; Yakushiji H; Fujii Y; Kishi Y; Kita S; Shen L; Kumon H; Matsuura E
    J Immunol Res; 2015; 2015():268172. PubMed ID: 25883990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.
    Yuan J; Kashiwagi S; Reeves P; Nezivar J; Yang Y; Arrifin NH; Nguyen M; Jean-Mary G; Tong X; Uppal P; Korochkina S; Forbes B; Chen T; Righi E; Bronson R; Chen H; Orsulic S; Brauns T; Leblanc P; Scholler N; Dranoff G; Gelfand J; Poznansky MC
    J Hematol Oncol; 2014 Feb; 7():15. PubMed ID: 24565018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases.
    Avula LR; Rudloff M; El-Behaedi S; Arons D; Albalawy R; Chen X; Zhang X; Alewine C
    Mol Cancer Res; 2020 Feb; 18(2):229-239. PubMed ID: 31676721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer.
    Cao B; Liu M; Wang L; Liang B; Feng Y; Chen X; Shi Y; Zhang J; Ye X; Tian Y; Zhi C; Li J; Lian H; Wu Q; Zhang Z
    Biochem Biophys Res Commun; 2020 Mar; 524(1):96-102. PubMed ID: 31980173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel immunocytokine IL12-SS1 (Fv) inhibits mesothelioma tumor growth in nude mice.
    Kim H; Gao W; Ho M
    PLoS One; 2013; 8(11):e81919. PubMed ID: 24260587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.
    Scholler N; Fu N; Yang Y; Ye Z; Goodman GE; Hellström KE; Hellström I
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11531-6. PubMed ID: 10500211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a Transgenic BALB/c Mouse Line With Selective Expression of Human Mesothelin in Thyroid Gland: Application in Mesothelin-targeted Immunotherapy.
    Bera TK; Liu W; Leshem J; King E; Kozlov S; Pastan I
    J Immunother; 2019 May; 42(4):119-125. PubMed ID: 30933045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Carcinogenesis; 2011 Jul; 32(7):1013-24. PubMed ID: 21515913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.